- Poor cardiovascular-kidney-metabolic health (CKM) health has significant implications for adverse clinical outcomes, most notably cardiovascular morbidity and premature mortality; however, there is a growing array of therapies and healthcare strategies that have great potential to improve outcomes for the patient with CKM syndrome.
- Given the growing number of available therapies that simultaneously target different components of CKM, novel risk prediction equations are needed that incorporate predictors and outcomes clinically relevant to the CKM context.
- This scientific statement follows a Presidential Advisory and Synopsis Statement on CKM health and summarizes the background, rationale, and clinical implications for the newly developed sex-specific, race-free risk equations.
Read the full Scientific Statement in Circulation
Read the full Presidential Advisory in Circulation
Read the Synopsis of the Evidence in Circulation